NCT03885882View on ClinicalTrials.gov

A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 13, 2019

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Healthy Subjects
Interventions
DRUG

E0302 SR1

E0302 SR1, oral tablet.

DRUG

E0302 SR3

E0302 SR3, oral tablet.

DRUG

E0302 SR2

E0302 SR2, oral tablet.

DRUG

E0302 IR

E0302 IR, oral tablet.

Trial Locations (1)

Unknown

Auckland Clinical Studies, Auckland

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT03885882 - A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants | Biotech Hunter | Biotech Hunter